Literature DB >> 33239270

KCC2 Chloride Transport Contributes to the Termination of Ictal Epileptiform Activity.

Volodymyr I Dzhala1,2, Kevin J Staley1,2.   

Abstract

Recurrent seizures intensely activate GABAA receptors (GABAA-Rs), which induces transient neuronal chloride ([Cl-]i) elevations and depolarizing GABA responses that contribute to the failure of inhibition that engenders further seizures and anticonvulsant resistance. The K+-Cl- cotransporter KCC2 is responsible for Cl- extrusion and restoration of [Cl-]i equilibrium (ECl) after synaptic activity, but at the cost of increased extracellular potassium which may retard K+-Cl- extrusion, depolarize neurons, and potentiate seizures. Thus, KCC2 may either diminish or facilitate seizure activity, and both proconvulsant and anticonvulsant effects of KCC2 inhibition have been reported. It is now necessary to identify the loci of these divergent responses by assaying both the electrographic effects and the ionic effects of KCC2 manipulation. We therefore determined the net effects of KCC2 transport activity on cytoplasmic chloride elevation and Cl- extrusion rates during spontaneous recurrent ictal-like epileptiform discharges (ILDs) in organotypic hippocampal slices in vitro, as well as the correlation between ionic and electrographic effects. We found that the KCC2 antagonist VU0463271 reduced Cl- extrusion rates, increased ictal [Cl-]i elevation, increased ILD duration, and induced status epilepticus (SE). In contrast, the putative KCC2 upregulator CLP257 improved chloride homeostasis and reduced the duration and frequency of ILDs in a concentration-dependent manner. Our results demonstrate that measuring both the ionic and electrographic effects of KCC2 transport clarify the impact of KCC2 modulation in specific models of epileptiform activity. Anticonvulsant effects predominate when KCC2-mediated chloride transport rather than potassium buffering is the rate-limiting step in restoring ECl and the efficacy of GABAergic inhibition during recurrent ILDs.
Copyright © 2020 Dzhala and Staley.

Entities:  

Keywords:  CLP257; GABA; KCC2; VU0463271; chloride; seizure

Mesh:

Substances:

Year:  2021        PMID: 33239270      PMCID: PMC7986536          DOI: 10.1523/ENEURO.0208-20.2020

Source DB:  PubMed          Journal:  eNeuro        ISSN: 2373-2822


  63 in total

1.  Prototypic seizure activity driven by mature hippocampal fast-spiking interneurons.

Authors:  Yoko Fujiwara-Tsukamoto; Yoshikazu Isomura; Michiko Imanishi; Taihei Ninomiya; Minoru Tsukada; Yuchio Yanagawa; Tomoki Fukai; Masahiko Takada
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

2.  Extracellular free calcium and potassium during paroxsmal activity in the cerebral cortex of the cat.

Authors:  U Heinemann; H D Lux; M J Gutnick
Journal:  Exp Brain Res       Date:  1977-03-30       Impact factor: 1.972

3.  Traumatic alterations in GABA signaling disrupt hippocampal network activity in the developing brain.

Authors:  Volodymyr Dzhala; Guzel Valeeva; Joseph Glykys; Rustem Khazipov; Kevin Staley
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

4.  Furosemide and mannitol suppression of epileptic activity in the human brain.

Authors:  Michael M Haglund; Daryl W Hochman
Journal:  J Neurophysiol       Date:  2005-02-23       Impact factor: 2.714

Review 5.  Novel determinants of the neuronal Cl(-) concentration.

Authors:  Eric Delpire; Kevin J Staley
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

6.  Excitatory actions of endogenously released GABA contribute to initiation of ictal epileptiform activity in the developing hippocampus.

Authors:  Volodymyr I Dzhala; Kevin J Staley
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

7.  Glutamate, NMDA, and AMPA induced changes in extracellular space volume and tortuosity in the rat spinal cord.

Authors:  L Vargová; P Jendelová; A Chvátal; E Syková
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

8.  Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo.

Authors:  Sudhir Sivakumaran; Ross A Cardarelli; Jamie Maguire; Matt R Kelley; Liliya Silayeva; Danielle H Morrow; Jayanta Mukherjee; Yvonne E Moore; Robert J Mather; Mark E Duggan; Nicholas J Brandon; John Dunlop; Stephen Zicha; Stephen J Moss; Tarek Z Deeb
Journal:  J Neurosci       Date:  2015-05-27       Impact factor: 6.167

9.  Acute and chronic efficacy of bumetanide in an in vitro model of posttraumatic epileptogenesis.

Authors:  Volodymyr Dzhala; Kevin J Staley
Journal:  CNS Neurosci Ther       Date:  2014-12-12       Impact factor: 5.243

10.  Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures.

Authors:  Yvonne E Moore; Tarek Z Deeb; Heramb Chadchankar; Nicholas J Brandon; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

View more
  6 in total

1.  Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model.

Authors:  Brennan J Sullivan; Pavel A Kipnis; Brandon M Carter; Li-Rong Shao; Shilpa D Kadam
Journal:  Sci Signal       Date:  2021-11-09       Impact factor: 8.192

2.  Clarifications regarding bumetanide for neonatal seizures.

Authors:  Kevin J Staley
Journal:  Epilepsia       Date:  2022-05-26       Impact factor: 6.740

3.  Unique Actions of GABA Arising from Cytoplasmic Chloride Microdomains.

Authors:  Negah Rahmati; Kieran P Normoyle; Joseph Glykys; Volodymyr I Dzhala; Kyle P Lillis; Kristopher T Kahle; Rehan Raiyyani; Theju Jacob; Kevin J Staley
Journal:  J Neurosci       Date:  2021-04-26       Impact factor: 6.167

4.  Loss of KCC2 in GABAergic Neurons Causes Seizures and an Imbalance of Cortical Interneurons.

Authors:  Kirill Zavalin; Anjana Hassan; Cary Fu; Eric Delpire; Andre H Lagrange
Journal:  Front Mol Neurosci       Date:  2022-03-16       Impact factor: 5.639

5.  Discovery of Small Molecule KCC2 Potentiators Which Attenuate In Vitro Seizure-Like Activity in Cultured Neurons.

Authors:  Francis J Prael Iii; Kwangho Kim; Yu Du; Brittany D Spitznagel; Gary A Sulikowski; Eric Delpire; C David Weaver
Journal:  Front Cell Dev Biol       Date:  2022-06-24

Review 6.  Dysregulation of GABAergic Signaling in Neurodevelomental Disorders: Targeting Cation-Chloride Co-transporters to Re-establish a Proper E/I Balance.

Authors:  Enrico Cherubini; Graziella Di Cristo; Massimo Avoli
Journal:  Front Cell Neurosci       Date:  2022-01-05       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.